Instructions to Authors
All manuscripts submitted to Parkinson's Disease and Movement Disorders must be processed through the journal's online submission system. The online editorial office is accessible at https://submit.parkinson.org.tr/. Each submission is assigned a unique identification number and an automatic confirmation e-mail is sent to the corresponding author upon successful submission.
Language: The official language of the journal is Turkish and English.
It is strongly recommended that authors carefully review the policies and submission guidelines prior to manuscript submission to ensure full compliance. All manuscripts should be prepared in accordance with the recommendations of the International Committee of Medical Journal Editors (ICMJE) for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (updated May 2023). Authors are also advised to refer to the EASE Guidelines for Authors and Translators, and to format manuscripts in accordance with the 11th edition of the AMA Manual of Style.
1. Reporting Guidelines
Authors must ensure that their manuscripts comply with the appropriate reporting guidelines according to the study design:
- Randomized controlled trials → CONSORT (protocols: SPIRIT)
- Observational studies → STROBE
- Diagnostic accuracy studies → STARD
- Systematic reviews & meta-analyses → PRISMA (protocols: PRISMA-P)
- Experimental animal research → ARRIVE + Guide for Laboratory Animals, 8th ed.
- Non-randomized behavioral/public health interventions → TREND
- Case reports → CARE
- Genetic association research → STREGA
- Qualitative research → SRQR
To identify the most appropriate guideline for your study, use the EQUATOR Network reporting guideline selection tool. Authors are also encouraged to consider the Sex and Gender Equity in Research (SAGER) guidelines.
2. Editorial Policy
Required Documents at Submission
Along with the manuscript files, authors must submit the following documents at the time of initial submission:
- Copyright Agreement and Acknowledgement of Authorship Form
- ICMJE Potential Conflict of Interest Disclosure Form (to be completed by all contributing authors)
These forms can be downloaded from the online submission system at https://submit.parkinson.org.tr/.
3. Manuscript Preparation
3.1. General Guidelines
- Manuscripts should be prepared using Microsoft Word. The preferred font is 12-point Times New Roman; text must be double-spaced throughout, including the title page, abstract, main text, references, tables, and figure legends.
- Manuscripts should be arranged in the following order: (1) Abstract, (2) Main Text, (3) Acknowledgments, (4) Disclosures, (5) References, (6) Tables, (7) Figure(s) and Figure Legends. All pages must be numbered consecutively from the title page.
- The recommended length for an original article or review is a maximum of 20 double-spaced pages, including one title page, one abstract page, approximately 10 pages of main text (~2,250 words), up to three pages of references, and one legends page. Tables should be on separate pages.
- Always use leading zeros in decimal fractions. Report values and percentages to one decimal place unless greater precision is required (e.g., 12.3, not 12.34).
- Case Report text should not exceed eight double-spaced pages (~1,000 words), excluding the title page, abstract, and references. If tables or figures are included, reduce the text by approximately 125 words per item.
- Correspondence (Letters to the Editor) should not exceed two double-spaced pages (~500 words) and should include no more than four references.
- Reviews should not exceed 4,000 words; Editorials are limited to 2,500 words.
- Invited Letters are accepted only from invited authors and should not exceed 2,000 words, including an abstract of no more than 250 words.
Manuscript Type Limits
| Type of Manuscript | Word Count* | Abstract (words) | References | Authors |
|---|---|---|---|---|
| Original Article | 2,250 | 250 | 35 | 8 |
| Case Report | 1,000* | 100 | 6 | 5 |
| Review Article | 4,000 | 100 | 85 | 8 |
| Letters to the Editor | 500 | N/A | 4 | 3 |
| Editorial | 2,500 | N/A | 25 | 4 |
| Invited Letters | 2,000 | 250 | 25 | 5 |
|
* Excludes abstract, references, tables, and figure legends. If tables or illustrations are included, reduce the total word count by 125 words per item. Word limits are strictly enforced. Submissions exceeding these limits may be returned prior to peer review. |
||||
3.2. Title Page
- Provide a concise and informative title not exceeding 95 characters (including spaces) for Original Articles, and 80 characters for Case Reports, Correspondence, and How to Do It articles. Avoid abbreviations in the title.
- A short running title of no more than 40–50 characters must also be provided.
- Include the full names of all authors directly affiliated with the work. Maximum authors: 8 for Original Articles, 5 for Case Reports and How to Do It articles, 3 for Correspondence. Exceeding numbers must be justified to the Editor.
- List no more than two institutional affiliations where the work was conducted. If more than one is listed, indicate the affiliation of each author.
- If the manuscript was or will be presented at a congress, include the meeting name, date, and location as a footnote.
- At the bottom of the title page, provide the full name, postal address (with zip code), telephone number, fax number, and e-mail address of the corresponding author.
- The title page must be uploaded as a separate file. The main text file must not contain author or institution names.
3.3. Abstracts
- Original Articles: structured abstract ≤250 words, with the headings Background, Methods, Results, and Conclusion.
- Case Reports and Review Articles: unstructured abstract ≤100 words.
- Letters to the Editor and Editorials: no abstract required.
- Invited Letters: unstructured abstract ≤100 words.
- Provide 3–5 keywords selected from MeSH terms below the abstract.
- Avoid abbreviations in abstracts; if necessary, define at first mention.
3.4. Text
The main text should generally follow: Introduction → Materials and Methods → Results → Discussion.
- The Introduction should state the background, rationale, and objectives of the study.
- Materials and Methods must describe the study setting, time period, and design in sufficient detail to allow reproducibility.
- Statistical comparisons should be reported together with the corresponding results in the Results section.
- In the Discussion, interpret findings in the context of current literature; address limitations before the conclusion.
- Number references, tables, and figures consecutively in order of first citation.
- Avoid abbreviations; if necessary, define at first mention. Do not use abbreviations in the title or abstract.
- Use standard metric units for all measurements and weights.
- Acknowledge grants, financial support, or technical assistance at the end of the text, before References.
- For drugs, equipment, or brand-name materials, provide the company name and location in parentheses.
3.5. References
- References should be selective and directly relevant to the work. Avoid excessive referencing.
- Do not cite personal communications, manuscripts in preparation, or unpublished data.
- Number references consecutively in order of first citation; type double-spaced on a separate page.
- Cite using Arabic numerals in square brackets [ ], preferably superscript. When a first author's surname is mentioned, follow with et al. and the reference number (e.g., Smith et al.[1]).
- For consecutive references, use a hyphen: [1–3], [8–14].
- List all authors if six or fewer; if more, list the first six followed by et al.
- Abbreviate journal titles as in Index Medicus. Authors are solely responsible for the accuracy of all references.
Reference Formats
Journal Article
Case Report
Presentations
Book
Chapter in a Book
Internet Address
3.6. Tables
- Type double-spaced on separate Microsoft Word pages. Each table must be identified by an Arabic numeral and accompanied by a concise title placed above the table.
- Explanatory notes and legends should be placed below the table. All abbreviations must be listed alphabetically and defined in full.
- Previously published tables must be cited in accordance with the CC BY 4.0 license terms.
- Tables should be self-explanatory and must not duplicate data already in the text or figures.
3.7. Figure Legends
- Type double-spaced and list sequentially on a separate page. Figure numbers must be Arabic and correspond to the order of appearance in the text.
- List all abbreviations alphabetically at the end of each legend.
- For photomicrographs, state the type of stain and magnification.
- Previously published figures must be cited in accordance with the CC BY 4.0 license terms.
- Provide signed consent forms for recognizable (unmasked) photographs of human subjects.
3.8. Illustrations
- Submit images as separate files named by figure designation (e.g., Figure 1A, Figure 2B). Accepted formats: TIFF and JPEG. PowerPoint (.ppt) is accepted for line drawings only (one file per figure).
- Previously published illustrations must be cited in accordance with the CC BY 4.0 license terms.
- Written informed consent must be obtained for recognizable patient photographs; signed forms must be submitted to the editorial office.
- If electronic artwork is deemed insufficient for high-quality reproduction after acceptance, original illustrations may be requested.
4. Scientific Responsibility Statement
Prior to publication, each author must certify participation sufficient to take public responsibility for a meaningful portion of the manuscript content. Such participation must include all of the following:
- Substantial contributions to the conception or design, or to the acquisition, analysis, or interpretation of data;
- Drafting the manuscript or critically revising it for important intellectual content;
- Final approval of the version to be published.
Turkish Parkinson's Disease Society
Halil Rıfat Paşa Mah., Güler Sok., No: 33, Kat: 1, 34400 Okmeydanı, Şişli, İstanbul, Türkiye
Tel: +90 (212) 220 36 18 | Fax: +90 (212) 296 05 79
E-mail: iletisim@parkinsondernegi.com
Web: https://parkinson.org.tr